Maverakis E, Marzano AV, Le ST, Callen JP, Bruggen MC, Guenova E, et al. Pyoderma gangrenosum. Nat Rev Dis Primers. 2020;6(1):81.
Monari P, Moro R, Motolese A, Misciali C, Baraldi C, Fanti PA, et al. Epidemiology of pyoderma gangrenosum: results from an Italian prospective multicentre study. Int Wound J. 2018;15(6):875–9.
Article PubMed PubMed Central Google Scholar
George C, Deroide F, Rustin M. Pyoderma gangrenosum—a guide to diagnosis and management. Clin Med (Lond). 2019;19(3):224–8.
Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin N Am. 2007;33(4):787–802, vi.
Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244–50.
Article CAS PubMed Google Scholar
Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol. 2015;73(4):691–8.
Article CAS PubMed Google Scholar
Schmieder SJ, Krishnamurthy K. Pyoderma gangrenosum. Treasure Island: StatPearls; 2024.
Oprea Y, Kody S, Shakshouk H, Greiling TM, Anstey KM, Ortega-Loayza AG. What can inherited immunodeficiencies reveal about pyoderma gangrenosum? Exp Dermatol. 2024;33(1): e14954.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.
Article PubMed PubMed Central Google Scholar
Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64.
Article PubMed PubMed Central Google Scholar
Aladbe B. Childhood autoinflammatory disorders in Qatar. Pediatr Rheumatol. 2013;11:A114.
Bergbreiter A, Jaeger T, Karle A, Bitzinger D, Ettl T, Spanier G, et al. Recurrent necrotizing cellulitis, multi-organ autoimmune disease and humoral immunodeficiency due to a novel NFKB1 frameshift mutation. Eur J Med Genet. 2021;64(3):104144.
Article CAS PubMed Google Scholar
Bondarenko AV, Boyarchuk OR, Sakovich IS, Polyakova EA, Migas AA, Kupchinskaya AN, et al. Variable CD18 expression in a 22-year-old female with leukocyte adhesion deficiency I: clinical case and literature review. Clin Case Rep. 2023;11(8):e7791.
Article PubMed PubMed Central Google Scholar
Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)—a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66(3):409–15.
Calderon-Castrat X, Bancalari-Diaz D, Roman-Curto C, Romo-Melgar A, Amoros-Cerdan D, Alcaraz-Mas LA, et al. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol. 2016;175(1):194–8.
Article CAS PubMed Google Scholar
Cantisani C, Naqeshbandi AF, Goldust M, Lampitelli S, Cantoresi F, Alsorori E. Type I leucocyte adhesion deficiency in Yemenian family managed with appropriate treatment: a case series. Dermatol Ther. 2019;32(3):e12864.
Constantinou M, Parperis K. Pyoderma gangrenosum in a patient with familial Mediterranean fever and chronic inflammatory seronegative arthropathy: a unique triad. BMJ Case Rep. 2022;15(7):e250060.
Coors EA, von den Driesch P. Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency. Br J Dermatol. 2000;143(1):154–6.
Article CAS PubMed Google Scholar
Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, et al. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum. 2012;64(6):2022–7.
Nievas E. Skin disease related to NFKB1 abnormality improve by anti IL1 treatment. Selected abstracts from the 12th annual meeting of the Clinical Immunology Society: 2021 virtual annual meeting: immune deficiency and dysregulation North American conference. J Clin Immunol. 2021; 41(1): 1–135.
Fang R, Wang J, Jiang XY, Wang SH, Cheng H, Zhou Q. Case report: a novel mutation in NFKB1 associated with pyoderma gangrenosum. Front Genet. 2021;12: 673453.
Article PubMed PubMed Central Google Scholar
Friduss SR, Sadoff WI, Hern AE, Fivenson DP. Fatal pyoderma gangrenosum in association with C7 deficiency. J Am Acad Dermatol. 1992;27(2 Pt 2):356–9.
Article CAS PubMed Google Scholar
Geusau A, Mothes-Luksch N, Nahavandi H, Pickl WF, Wise CA, Pourpak Z, et al. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol. 2013;149(2):209–15.
Article CAS PubMed Google Scholar
Haynes AOKA, Dancey P, Ohson K, Turner L, Chard M. Leukocyte adhesion deficiency-I caused by a novel mutation in ITGB2 presenting with pyoderma gangrenosum. LymphoSign J. 2018;5:86–90.
Hieta N, Nuutinen H, Roivas J, Salminen K, Kujari H, Talve L, et al. Severe ulcerative proctitis, pyoderma gangrenosum, hidradenitis suppurativa and fever in a patient with a rare variant of the PSTPIP1 gene. Clin Exp Dermatol. 2021;46(7):1387–90.
Article CAS PubMed Google Scholar
Hoffmann P, Ombrello AK, Stone DL, Barron KS, Kastner DL. Combination TNF and IL-1 blockade in PAPA syndrome. Pediatr Rheumatol. 2013;11(1):A243.
Honda Y, Otsuka A, Yamashita K, Takaori-Kondo A, Kabashima K. MEFV gene mutation in two cases of pyoderma gangrenosum with aseptic arthritis. J Eur Acad Dermatol Venereol. 2016;30(12):e183–4.
Article CAS PubMed Google Scholar
Iglesias E, Roldan M, Vlagea A, Solís-Moruno M, Mosquera JM, Bitterman V, et al. Recurrent fever, recurrent pyoderma gangrenosum-like and bacterial infections due to a novel homozygous WDR1 mutation in a child treated with allogeneic hematopoietic stem cell transplantation. Pediatr Rheumatol. 2019;17:97.
Joseph N, Hostoffer R, Tcheurekdjian H. A novel gene mutation associated with common variable immunodeficiency and pyoderma. Ann Allergy Asthma Immunol. 2018;121:S94.
Karaca Edeer N, Aykut A, Pariltay E, Aksu G, Cogulu O, Kutukculer N. A novel TTC37 mutation causing clinical symptoms of trichohepatoenteric syndrome such as pyoderma gangrenosum and immunodeficiency without severe diarrhea. J Investig Allergol Clin Immunol. 2019;29(5):396–8.
Article CAS PubMed Google Scholar
Kotzerke M, Mitri F, Marbach F, Enk A, Haenssle H. A case of PAPASH syndrome in a young man carrying a novel heterozygote missense variant in PSTPIP1. J Eur Acad Dermatol Venereol. 2021;35(7):e439–40.
Article CAS PubMed Google Scholar
Lin MT, Chien YH, Shyur SD, Huang LH, Chiang YC, Wen DC, et al. De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma. Ann Allergy Asthma Immunol. 2006;96(5):744–8.
Article CAS PubMed Google Scholar
Lindwall E, Singla S, Davis WE, Quinet RJ. Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome. Semin Arthritis Rheum. 2015;45(1):91–3.
Article CAS PubMed Google Scholar
Madkaikar M, Italia K, Gupta M, Desai M, Aggarwal A, Singh S, et al. Leukocyte adhesion deficiency-I with a novel intronic mutation presenting with pyoderma gangrenosum-like lesions. J Clin Immunol. 2015;35(4):431–4.
Article CAS PubMed Google Scholar
Marzano AV, Ceccherini I, Gattorno M, Fanoni D, Caroli F, Rusmini M, et al. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltim). 2014;93(27): e187.
Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2017;176(6):1588–98.
Article CAS PubMed Google Scholar
Marzano AV, Ortega-Loayza AG, Ceccherini I, Cugno M. LPIN2 gene mutation in a patient with overlapping neutrophilic disease (pyoderma gangrenosum and aseptic abscess syndrome). JAAD Case Rep. 2018;4(2)
留言 (0)